我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

血管内皮祖细胞与经皮冠状动脉介入治疗术后再狭窄及其应用前景

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2010年第5期
页码:
764-766,780
栏目:
综述
出版日期:
2010-06-22

文章信息/Info

Title:
-
作者:
汪征 综述; 李自成 审校
暨南大学附属第一医院心内科，广东 广州 510630
Author(s):
-
关键词:
血管内皮祖细胞; 经皮冠状动脉介入治疗术; 再狭窄
Keywords:
-
分类号:
R543.3
DOI:
-
文献标识码:
A
摘要:
血管内皮祖细胞(EPCs),也称血管干细胞、血管内皮母细胞。EPCs的发现，为经皮冠状动脉介入治疗术(PCI)后再狭窄的防治提供了新的思路。
Abstract:
-

参考文献/References

［1］Rohde E, Malischnik C, Thaler D, et al. Blood monocytes mimic endothelial progenitor cells［J］. Stem Cells, 2006, 24(3):357-367.

［2］Walenta K, Friedrich EB, Sehnert F, et al. In vitro differentiation characteristics of cultured human mononuclear cells-implications for endothelial progenitor cell biology［J］. Biochem Biophys Res Commun, 2005, 333(2):476-482.

［3］ Romagnani P, Annunziato F, Liotta F, et al. CD14+CD34 low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors［J］. Circ Res, 2005, 97(4):314-322.

［4］Ghani U, Shuaib A, Salam A, et al. Endothelial progenitor cells during cerebrovascular disease［J］. Stroke, 2005, 36(1):151-153.

［5］Heiss C, Keymel S, Niesler U, et al. Impaired progenitor cell activity in age-related endothelial dysfunction［J］. J Am Coll Cardiol, 2005, 45(9):1441-1448.

[6]吴钟伟,张怀勤. 内皮祖细胞与治疗性血管新生［J］. 心脏杂志, 2009, 21(4):581-584.

[7]Ii M, Takenaka H, Asai J, et al. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial inju［J］. Circ Res, 2006, 98 (5):697-704.

[8]Li X, Han Y, Pang W, et al. AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells［J］. Arterioscler Thromb Vasc Biol, 2008, 28(10):1789-1795.

[9]Hao H, Tan Y, Eton D, et al. Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels［J］. Stem Cells, 2008, 26(5):1376-1384.

[10]Park KW, Hwang KK, Cho HJ, et al. Simvastatin enhances endothelial differentiation of peripheral blood mononuclear cells in hypercholesterolemic patients and induces pro-angiogenic cytokine IL-8 secretion from monocytes［J］. Clinica Chimica Acta, 2008, 388(1-2):156-166.

[11]Henrich D, Seebach C, Wilhelm K, et al. High dosage of simvastatin reduces TNF-α-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1β in vitro［J］. J Surg Res, 2007, 142(1):13-19.

[12]Hristov M, Fach C, Becker C, et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment［J］. Atherosclerosis, 2007, 192(2):413-420.

[13]Spiel AO, Mayr FB, Leitner JM, et al. Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation［J］. Throm Res, 2008, 123(1):108-113.

[14]Huang Y, Salu K, Wang L, et al. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine cornary model［J］. Invasive Cardiol, 2005, 17(3):142-148.

[15]成威,周胜华. 内皮抑素和血管内皮在再狭窄中的作用［J］. 心脏杂志, 2009, 21(4):585-587.

[16]陈丹,吕安林,苑媛,等. 药物涂层支架研究进展［J］. 心脏杂志, 2006, 18(5):591-594.

[17]Morice MC, Serruys PW, Barragan P, et al. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial［J］. J Am Coll Cardiol, 2007, 50(14):1299-1304.

[18]Weisz G, Leon MB, Holmes DR, et al. Two year outcomes after sirolimus-eluting stent imp lantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIR IUS) trial［J］. J Am Coll Cardiol, 2006, 47(7):1350-1355.

[19]Ellis SG, Popma JJ, Lasala JM, et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent imp lantation: analysis from the TAXUS-IV trial［J］. J Am Coll Cardiol, 2005, 45(8):1193-1200.

[20]李华,杨守忠,柴志勇,等. 阿托伐他汀对冠心病患者PCI 术后再狭窄的影响［J］. 中国医药导报, 2007, 4(15):69.

[21]Blindt R, Vogt F, Astafieva I, et al. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells［J］. J Am Coll Cardiol, 2006, 47(9):1786-1795.

[22]Aoki J, Serruys PW, van Beusekom H, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry［J］. J Am Coll Cardiol, 2005, 45(10):1574-1579.

[23]Miglionico M, Patti G, Ambrosio AD, et al. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent:a prospective single-center registry in high-risk patients［J］. Cathete Cardiovasc Interve, 2008, 71(5):600-604.

备注/Memo

备注/Memo:
收稿日期：2009-09-23.通讯作者：李自成，教授，主要从事冠心病的诊治研究Email:zichengli@163.net 作者简介：汪征，硕士生Email:wangzheng070385@163.com
更新日期/Last Update: 2010-06-22